Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Melatonin for Dental Implant Osseointegration
NCT04229719Phase 3Unknown
- Sponsor
- University of Baghdad
- Start
- Nov 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in Alveolar bone loss, sponsored by University of Baghdad. Status: unknown.
02
Drugs
melatonin
03
Conditions
Alveolar bone loss
Beyond the preview
Go deeper on NCT04229719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04229719.